MD1732F1 - Method of prognosticating the duodenal ulcerous disease evolution - Google Patents

Method of prognosticating the duodenal ulcerous disease evolution

Info

Publication number
MD1732F1
MD1732F1 MD20010117A MD20010117A MD1732F1 MD 1732 F1 MD1732 F1 MD 1732F1 MD 20010117 A MD20010117 A MD 20010117A MD 20010117 A MD20010117 A MD 20010117A MD 1732 F1 MD1732 F1 MD 1732F1
Authority
MD
Moldova
Prior art keywords
duodenal
ulcerous
prognosticating
disease evolution
determined
Prior art date
Application number
MD20010117A
Other languages
Romanian (ro)
Other versions
MD1732G2 (en
Inventor
Ion Tabarna
Original Assignee
Ion Tabarna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ion Tabarna filed Critical Ion Tabarna
Priority to MDA20010117A priority Critical patent/MD1732G2/en
Publication of MD1732F1 publication Critical patent/MD1732F1/en
Publication of MD1732G2 publication Critical patent/MD1732G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely, to therapy and gastroenterology. Summary of the invention consists in that there are determined the patient's age, heredity, blood group, body mass deficit, pain syndrom intensity, it is carried out an atropinic test and it is endoscopic determined localization, dimension, time of cicatrisation of the ulcerous defect, as well as the gastritis and/or bulbitis form. The obtained data receive the corresponding values which are summed up, thereafter according to the obtained values sum the variant of the duodenal ulcerous disease evolution is prognosticated.Claims: 1
MDA20010117A 2001-05-02 2001-05-02 Method of prognosticating the duodenal ulcerous disease evolution MD1732G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010117A MD1732G2 (en) 2001-05-02 2001-05-02 Method of prognosticating the duodenal ulcerous disease evolution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010117A MD1732G2 (en) 2001-05-02 2001-05-02 Method of prognosticating the duodenal ulcerous disease evolution

Publications (2)

Publication Number Publication Date
MD1732F1 true MD1732F1 (en) 2001-09-30
MD1732G2 MD1732G2 (en) 2002-03-31

Family

ID=19739820

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010117A MD1732G2 (en) 2001-05-02 2001-05-02 Method of prognosticating the duodenal ulcerous disease evolution

Country Status (1)

Country Link
MD (1) MD1732G2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3161G2 (en) * 2006-03-23 2007-05-31 Елена КРЯНГЭ Method of gastroduodenal affection prognostication
MD726Z (en) * 2013-07-23 2014-08-31 Адриан КИШКА Method for prognosticating the evolution of gastric precancerous states in men

Also Published As

Publication number Publication date
MD1732G2 (en) 2002-03-31

Similar Documents

Publication Publication Date Title
ATE468137T1 (en) INHIBITORS OF HMGB1 FOR THE TREATMENT OF TISSUE DISEASES
EA200300845A1 (en) MODIFIED ANTIBODIES AND METHODS OF APPLICATION
DK1131096T3 (en) Anti-CD20 antibody therapy in patients receiving bone marrow or peripheral blood stem cell transplants
DE60325404D1 (en) DEVICE FOR DETERMINING THE DIALYSIS EFFICIENCY
EP2292649A3 (en) Therapeutic epitopes and uses thereof
EP2172246A3 (en) Methods for Alzheimer's disease treatment and cognitive enhancement
YU37304A (en) Specific binding agents of human angiopoietin-2
NO890224L (en) PROCEDURE AND DEVICE FOR MEDICAL TREATMENT OF THE PATHOLOGICAL CONDITION OF BONE.
WO2004004542A3 (en) Method and device for use in tissue approximation and fixation
WO2002103492A3 (en) Therapeutic decisions systems and method using stochastic techniques
ATE355852T1 (en) USE OF BOTULINUM TOXIN FOR THE TREATMENT OF HEART AND Circulatory Diseases
ATE340542T1 (en) BREAST PROSTHESIS
TR199903154T2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
ATE201275T1 (en) DEMONSTRATION DEVICE IN THE SHAPE OF A LIVING BEING
Quade et al. Life on a Napoleonic battlefield: A bioarchaeological analysis of soldiers from the Battle of Aspern, Austria
Subasi et al. Supracondylar process of the humerus
WO2002046221A3 (en) Human protein differentially expressed in alzheimer's disease's brain
MD1732F1 (en) Method of prognosticating the duodenal ulcerous disease evolution
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
HUP0401188A2 (en) Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander
DE69230881D1 (en) CORTICOTROPINE RELEASE FACTOR-BINDING PROTEIN
HUP0203486A2 (en) Prevention and treatment of diseases associated with blood coagulation
WO2005028608A3 (en) Cell processor for use in the treatment of diseases
Pusceddu et al. Phoenician-Punic Inhumations from Othoca Necropolis (Santa Severa, Santa Giusta-Or)